Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|January 24, 2020
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter studyDavid Tougeron, Benjamin Sueur, Aziz Zaanan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2024
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world studyJeannie M'Baloula, David Tougeron, Alice Boilève, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2023
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trialCyrille Féray, Loic Campion, Philippe Mathurin, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2025
Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO studyIona Campo-Le-Brun, Emma Grapinet, Valerie Aurillac, et al.
The Lancet. Gastroenterology & Hepatology|April 8, 2019
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, et al.
Eclinicalmedicine|April 23, 2026
Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patientsBoris Guiu, Clément Bailly, Eric Vibert, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|November 10, 2020
Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post-EMA-approval descriptive study with a geriatric oncology focusJean-Philippe Metges, Jean-Yves Douillard, Jean-François Ramée, et al.
The Lancet. Oncology|June 1, 2026
[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trialEric Baudin, Alice Durand, Amandine Beron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
Long-term survival and cure fraction in patients with advanced hepatocellular carcinoma under immunotherapy in randomized controlled trials and real-world dataClaudia Campani, Ju Hyun Shim, Mohamed Bouattour, et al.
Lancet (London, England)|January 28, 2025
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trialThierry André, Elena Elez, Heinz-Josef Lenz, et al.
Pageof 9